{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:48:59Z","timestamp":1792511339815,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["Framework Contract No. ECDC\/2017\/004"],"award-info":[{"award-number":["Framework Contract No. ECDC\/2017\/004"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of <jats:italic>Neisseria gonorrhoeae<\/jats:italic> susceptibility to therapeutically relevant antimicrobials across the European Union\/European Economic Area (EU\/EEA). We present the Euro-GASP results from 2019 (26 countries), linked to patient epidemiological data, and compared with data from previous years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Agar dilution and minimum inhibitory concentration (MIC) gradient strip methodologies were used to determine the antimicrobial susceptibility (using EUCAST clinical breakpoints, where available) of 3239\u00a0N<jats:italic>. gonorrhoeae<\/jats:italic> isolates from 26 countries across the EU\/EEA. Significance of differences compared with Euro-GASP results in previous years was analysed using Z-test and the Pearson's \u03c72 test was used to assess significance of odds ratios for associations between patient epidemiological data and antimicrobial resistance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>European <jats:italic>N. gonorrhoeae<\/jats:italic> isolates collected between 2016 and 2019 displayed shifting MIC distributions for; ceftriaxone, with highly susceptible isolates increasing over time and occasional resistant isolates each year; cefixime, with highly-susceptible isolates becoming increasingly common; azithromycin, with a shift away from lower MICs towards higher MICs above the EUCAST epidemiological cut-off (ECOFF); and ciprofloxacin which is displaying a similar shift in MICs as observed for azithromycin. In 2019, two isolates displayed ceftriaxone resistance, but both isolates had MICs below the azithromycin ECOFF. Cefixime resistance (0.8%) was associated with patient sex, with resistance higher in females compared with male heterosexuals and men-who-have-sex-with-men (MSM). The number of countries reporting isolates with azithromycin MICs above the ECOFF increased from 76.9% (20\/26) in 2016 to 92.3% (24\/26) in 2019. Isolates with azithromycin MICs above the ECOFF (9.0%) were associated with pharyngeal infection sites. Following multivariable analysis, ciprofloxacin resistance remained associated with isolates from MSM and heterosexual males compared with females, the absence of a concurrent chlamydial infection, pharyngeal infection sites and patients\u2009\u2265\u200925\u00a0years of age.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Resistance to ceftriaxone and cefixime remained uncommon in EU\/EEA countries in 2019 with a significant decrease in cefixime resistance observed between 2016 and 2019. The significant increase in azithromycin \u201cresistance\u201d (azithromycin MICs above the ECOFF) threatens the effectiveness of the dual therapy (ceftriaxone\u2009+\u2009azithromycin), i.e., for ceftriaxone-resistant cases, currently recommended in many countries internationally and requires close monitoring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07509-w","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T09:02:41Z","timestamp":1654592561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Significant increase in azithromycin \u201cresistance\u201d and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019"],"prefix":"10.1186","volume":"22","author":[{"given":"Michaela J.","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Spiteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Kulishev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noshin","family":"Sajedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Blumel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J.","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Amato-Gauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Euro-GASP network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pleininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steliana","family":"Huhlescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irith","family":"de Baetselier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bla\u017eenka","family":"Hunjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana Nemeth","family":"Bla\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Maikanti-Charalampous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despo","family":"Pieridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Z\u00e1kouck\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"\u017demli\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Peetso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Viktorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndeindo","family":"Ndeikoundam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bercot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu Patari","family":"Sampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Kirjavainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Buder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivi","family":"Miriagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Dud\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu\u00f0r\u00fan","family":"Sigmundsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena Ros","family":"Asmundsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Carannante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Stefanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gatis","family":"Pakarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Mavcutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alje","family":"Van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ineke","family":"Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Kl\u00f8vstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Mlynarczyk-Bonikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jos\u00e9","family":"Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pavlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Klavs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Kustec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuncion","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Abad","family":"Torreblanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Velicko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Fifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"7509_CR1","doi-asserted-by":"crossref","unstructured":"Eyre DW, Sanderson ND, Lord E, Regisford-Reimmer N, Chau K, Barker L, et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Eurosurveillance. 2018;23(27).","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323"},{"issue":"25","key":"7509_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMc1512757","volume":"374","author":"H Fifer","year":"2016","unstructured":"Fifer H, Natarajan U, Jones L, Alexander S, Hughes G, Golparian D, et al. Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med. 2016;374(25):2504\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"7509_CR3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/cid\/cix485","volume":"65","author":"AR Katz","year":"2017","unstructured":"Katz AR, Komeya AY, Kirkcaldy RD, Whelen AC, Soge OO, Papp JR, et al. Cluster of Neisseria gonorrhoeae isolates with high-level azithromycin resistance and decreased ceftriaxone susceptibility, Hawaii, 2016. Clin Infect Dis. 2017;65(6):918\u201323.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"7509_CR4","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/jac\/dku118","volume":"69","author":"T Morita-Ishihara","year":"2014","unstructured":"Morita-Ishihara T, Unemo M, Furubayashi K, Kawahata T, Shimuta K, Nakayama S, et al. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae. J Antimicrob Chemother. 2014;69(8):2086\u201390.","journal-title":"J Antimicrob Chemother"},{"key":"7509_CR5","doi-asserted-by":"crossref","unstructured":"Poncin T, Fouere S, Braille A, Camelena F, Agsous M, Bebear C, et al. Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Eurosurveillance. 2018;23(21).","DOI":"10.2807\/1560-7917.ES.2018.23.21.1800264"},{"issue":"4","key":"7509_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jac\/dkaa526","volume":"76","author":"J Yan","year":"2021","unstructured":"Yan J, Chen Y, Yang F, Ling X, Jiang S, Zhao F, et al. High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China. J Antimicrob Chemother. 2021;76(4):936\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"7509_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s12879-018-3528-4","volume":"18","author":"MJ Day","year":"2018","unstructured":"Day MJ, Spiteri G, Jacobsson S, Woodford N, Amato-Gauci AJ, Cole MJ, et al. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. BMC Infect Dis. 2018;18(1):609.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"7509_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1071\/SH19023","volume":"16","author":"M Unemo","year":"2019","unstructured":"Unemo M, Lahra MM, Cole M, Galarza P, Ndowa F, Martin I, et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex Health. 2019;16(5):412\u201325.","journal-title":"Sex Health"},{"key":"7509_CR9","unstructured":"Unemo M LM, Escher M, Eremin S, Cole MJ, Galarza P, Ndowa F, Martin I, Dillon JR, Galas M, Ramon-Pardo P, Weinstock H, Wi T. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: a retrospective observational study. The Lancet Microbe. 2021; https:\/\/www.thelancet.com\/action\/showPdf?pii=S2666-5247%2821%2900171-3."},{"issue":"2","key":"7509_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/0956462420948739","volume":"32","author":"M Unemo","year":"2021","unstructured":"Unemo M, Ross J, Serwin AB, Gomberg M, Cusini M, Jensen JS. Background review for the \u20182020 European guideline for the diagnosis and treatment of gonorrhoea in adults.\u2019 Int J STD AIDS. 2021;32(2):108\u201326.","journal-title":"Int J STD AIDS"},{"key":"7509_CR11","first-page":"956462420949126","volume":"2020","author":"M Unemo","year":"2020","unstructured":"Unemo M, Ross J, Serwin AB, Gomberg M, Cusini M, Jensen JS. European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2020;2020:956462420949126.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"7509_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24(2):85\u201392.","journal-title":"Int J STD AIDS"},{"key":"7509_CR13","unstructured":"European Centre for Disease Control. Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe\u2014Indicator monitoring 2019. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/TRP-20201125-1523.pdf. 2021."},{"key":"7509_CR14","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0. http:\/\/www.eucast.org. 2019."},{"key":"7509_CR15","unstructured":"European Centre for Disease Control. Gonococcal antimicrobial susceptibility surveillance in the European Union\/European Economic Area Summary of results for 2019. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Gonococcal-antimicrobial-susceptibility-surveillance-2019.pdf. 2021."},{"key":"7509_CR16","doi-asserted-by":"crossref","unstructured":"Terkelsen D, Tolstrup J, Johnsen CH, Lund O, Larsen HK, Worning P, et al. Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Eurosurveillance. 2017;22(42).","DOI":"10.2807\/1560-7917.ES.2017.22.42.17-00659"},{"key":"7509_CR17","doi-asserted-by":"crossref","unstructured":"Golparian D, Rose L, Lynam A, Mohamed A, Bercot B, Ohnishi M, et al. Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Eurosurveillance. 2018;23(47).","DOI":"10.2807\/1560-7917.ES.2018.23.47.1800617"},{"key":"7509_CR18","doi-asserted-by":"crossref","unstructured":"Eyre DW, Town K, Street T, Barker L, Sanderson N, Cole MJ, et al. Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018. Eurosurveillance. 2019;24(10).","DOI":"10.2807\/1560-7917.ES.2019.24.10.1900147"},{"issue":"7","key":"7509_CR19","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1128\/AAC.00504-16","volume":"60","author":"S Nakayama","year":"2016","unstructured":"Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New Ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel Mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016;60(7):4339\u201341.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"7509_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3201\/eid2404.171873","volume":"24","author":"MM Lahra","year":"2018","unstructured":"Lahra MM, Martin I, Demczuk W, Jennison AV, Lee KI, Nakayama SI, et al. Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis. 2018;24(4):735\u201340.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"7509_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3201\/eid2402.171756","volume":"24","author":"B Lefebvre","year":"2018","unstructured":"Lefebvre B, Martin I, Demczuk W, Deshaies L, Michaud S, Labb\u00e9 AC, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Canada, 2017. Emerg Infect Dis. 2018;24(2):381\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"7509_CR22","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3201\/eid2507.190172","volume":"25","author":"SC Chen","year":"2019","unstructured":"Chen SC, Han Y, Yuan LF, Zhu XY, Yin YP. Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerg Infect Dis. 2019;25(7):1427\u20139.","journal-title":"Emerg Infect Dis"},{"key":"7509_CR23","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018. https:\/\/www.cdc.gov\/std\/stats18\/STDSurveillance2018-full-report.pdf. 2019."},{"issue":"03","key":"7509_CR24","first-page":"1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations Reports. 2015;64(03):1\u2013137.","journal-title":"MMWR Recommendations Reports."},{"key":"7509_CR25","doi-asserted-by":"crossref","unstructured":"Selb R, Buder S, Dudareva S, Tamminga T, Bremer V, Banhart S, et al. Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021. Eurosurveillance. 2021;26(31).","DOI":"10.2807\/1560-7917.ES.2021.26.31.2100616"},{"key":"7509_CR26","first-page":"44","volume":"2020","author":"MM Lahra","year":"2018","unstructured":"Lahra MM, Shoushtari M, George CRR, Armstrong BH, Hogan TR. Australian gonococcal surveillance programme annual report, 2019. Commun Dis Intell. 2018;2020:44.","journal-title":"Commun Dis Intell"},{"key":"7509_CR27","unstructured":"Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Australian STI management guidelines for use in primary care. http:\/\/www.stiguidelines.org.au\/sexually-transmissible-infections\/gonorrhoea\/. 2016."},{"issue":"1","key":"7509_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12879-021-05931-0","volume":"21","author":"S Jacobsson","year":"2021","unstructured":"Jacobsson S, Cole MJ, Spiteri G, Day M, Unemo M. Associations between antimicrobial susceptibility\/resistance of Neisseria gonorrhoeae isolates in European Union\/European Economic Area and patients\u2019 gender, sexual orientation and anatomical site of infection, 2009\u20132016. BMC Infect Dis. 2021;21(1):273.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"7509_CR29","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/cid\/ciz365","volume":"70","author":"HV Dong","year":"2020","unstructured":"Dong HV, Pham LQ, Nguyen HT, Nguyen MXB, Nguyen TV, May F, et al. Decreased cephalosporin susceptibility of oropharyngeal Neisseria species in antibiotic-using men who have sex with men in Hanoi, Vietnam. Clin Infect Dis. 2020;70(6):1169\u201375.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"7509_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s10156-007-0541-8","volume":"13","author":"R Furuya","year":"2007","unstructured":"Furuya R, Onoye Y, Kanayama A, Saika T, Iyoda T, Tatewaki M, et al. Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population. J Infect Chemother. 2007;13(5):302\u20134.","journal-title":"J Infect Chemother"},{"issue":"2","key":"7509_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/cid\/ciaa565","volume":"72","author":"JGE Laumen","year":"2021","unstructured":"Laumen JGE, Van Dijck C, Abdellati S, Manoharan-Basil SS, De Baetselier I, Martiny D, et al. Markedly reduced azithromycin and ceftriaxone susceptibility in commensal Neisseria species in clinical samples from Belgian men who have sex with men. Clin Infect Dis. 2021;72(2):363\u20134.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7509_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00182388","volume":"34","author":"BG Spratt","year":"1992","unstructured":"Spratt BG, Bowler LD, Zhang QY, Zhou J, Smith JM. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol. 1992;34(2):115\u201325.","journal-title":"J Mol Evol"},{"issue":"3","key":"7509_CR33","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587\u2013613.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"7509_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/sextrans-2014-051731","volume":"91","author":"DA Lewis","year":"2015","unstructured":"Lewis DA. Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains? Sex Transm Infect. 2015;91(4):234\u20137.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"7509_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/jac\/dky548","volume":"74","author":"FYS Kong","year":"2019","unstructured":"Kong FYS, Horner P, Unemo M, Hocking JS. Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review. J Antimicrob Chemother. 2019;74(5):1157\u201366.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"7509_CR36","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1186\/s12879-019-4631-x","volume":"19","author":"MJ Cole","year":"2019","unstructured":"Cole MJ, Quinten C, Jacobsson S, Day M, Amato-Gauci AJ, Woodford N, et al. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union\/European Economic Area. BMC Infect Dis. 2019;19(1):1040.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"7509_CR37","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1473-3099(18)30225-1","volume":"18","author":"SR Harris","year":"2018","unstructured":"Harris SR, Cole MJ, Spiteri G, S\u00e1nchez-Bus\u00f3 L, Golparian D, Jacobsson S, et al. Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey. Lancet Infect Dis. 2018;18(7):758\u201368.","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07509-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07509-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07509-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T20:04:57Z","timestamp":1654632297000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07509-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7509"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07509-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All examined gonococcal isolates were cultured and preserved as part of the routine diagnostics (standard care), and isolates or data were submitted to the Euro-GASP surveillance study with no patient identification information. Separate ethical approval was therefore not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"524"}}